Page last updated: 2024-10-25

deferoxamine and Hodgkin Disease

deferoxamine has been researched along with Hodgkin Disease in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koizumi, K1
Tonami, N1
Hisada, K1

Other Studies

1 other study available for deferoxamine and Hodgkin Disease

ArticleYear
Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.
    European journal of nuclear medicine, 1982, Volume: 7, Issue:5

    Topics: Animals; Breast Neoplasms; Deferoxamine; Female; Gallium Radioisotopes; Hodgkin Disease; Humans; Lun

1982